Os números da Dor

1. Airaksinen O, Brox JI, Cedraschi C, et al. Chapter 4. European guidelines for the management of chronicnonspecific low back pain. Eur Spine J. 2006 Mar;15 Suppl 2:S192-300.

2. Kaplan, W, Wirtz, V.J, Mantel-Teeuwisse, A, et al. Priority medicines for Europe and the World: 2013 update. World Health Organization; Geneva, Switzerland. 2003. Disponível em: http://www.who.int/medicines/areas/priority_medicines/MasterDocJune28_FINAL_Web.pdf?ua=1 (acedido a 16 de Maio de 2017).

3. Itz CJ, Geurts JW, van Kleef M, Nelemans P. Clinical course of non-specific low back pain: a systematic review of prospective cohort studies set in primary care. Eur J Pain. 2013;17(1):5-15.

4. Baron R, Binder A, Attal N, et al. Neuropathic low back pain in clinical practice. Eur J Pain. 2016 Jul;20(6):861-73.

5. Béatrice D. Priority Medicines for Europe and the World “A Public Health Approach to Innovation” Update on 2004 Background Paper, BP 6.24 Low back pain 2013; 6.24-24.

6. Rubin DI. Epidemiologyand risk factors for spine pain. Neurol Clin. 2007;25(2):353-71.

7. Maher C, Underwood M, Buchbinder R. Non‐specific low back pain. Lancet. 2016 Oct 10. pii: S0140-6736(16)30970-9.